Abstract
Background:
Immunosuppression is a risk factor for certain skin cancers. Autoimmune conditions can involve the skin, and may involve immunosuppressive therapies.
Methods:
We conducted a population-based case–control study among elderly US adults using Surveillance, Epidemiology, and End Results-Medicare-linked data of 44 613 skin cancer cases and 178 452 frequency-matched controls. Medicare claims identified autoimmune conditions. Adjusted odds ratios (ORs) compared prevalence in cases and controls.
Results:
The most frequent autoimmune condition was rheumatoid arthritis (2.29%), which was associated with slightly increased risk of Merkel cell carcinoma (N=1977; OR (95%CI): 1.39 (1.10–1.74)). Risk of cutaneous non-Hodgkin's lymphoma (N=2652) was increased with psoriasis (OR (95%CI): 3.20 (2.62–3.92)). Risk of Kaposi's sarcoma (N=773) was elevated with ulcerative colitis (OR (95%CI): 2.76 (1.42–5.39)), and risk of other sarcomas (N=1324) was elevated with Graves disease (2.62 (1.30–5.31)).
Conclusions:
These findings suggest that immune disturbances in the skin, arising from autoimmune conditions or their treatment, promote development of skin cancer.
Similar content being viewed by others
Main
Established risk factors for skin cancer include exposure to solar ultraviolet radiation, white race, and advancing age (Gruber and Armstrong). Immunosuppression also increases the risk of certain skin cancers. The risk in solid organ transplant recipients and people with human immunodeficiency virus (HIV) infection is extremely high for Kaposi's sarcoma (KS), a cutaneous tumour caused by human herpesvirus 8, somewhat elevated for cutaneous non-Hodgkin's lymphoma (NHL), Merkel cell carcinoma, and appendageal skin carcinomas and somewhat increased for melanoma (Lanoy et al, 2010).
Autoimmune conditions may also increase skin cancer risk. Chronic cutaneous inflammation that can characterise some autoimmune conditions (including psoriasis and scleroderma, which directly involve the skin) may plausibly cause DNA damage that could promote development of skin cancer. Immunosuppressive medications used to treat autoimmune conditions could have an additional role. This study aimed to investigate associations between autoimmune conditions and the subsequent risk of skin cancers among elderly US adults (aged 67 years and over).
Materials and methods
We selected subjects from the Surveillance, Epidemiology, and End Results (SEER)-Medicare data set, which links SEER cancer registry and Medicare claims data (Warren et al, 2002). Skin cancer cases (other than basal and squamous cell carcinomas) and cancer-free controls were selected as described elsewhere (Lanoy et al, 2010), updated to include SEER Medicare data through 2005. The presence of autoimmune conditions before cancer diagnosis/control selections was assessed using Medicare claims data: rheumatoid arthritis (International Classification of Disease version 9 codes 714.0-714.3, 714.81, V82.1), Sjörgren's syndrome (710.2), systemic lupus erythematosus (710.0), polymyalgia rheumatica (725), giant cell arteritis (446.5), Addison's disease (255.4), Graves disease (242.0), psoriasis (696.0-696.1), localised scleroderma (701.0), Crohn's disease (555), ulcerative colitis (556), and pernicious anaemia (281.0).
We used polytomous logistic regression to derive odds ratios (ORs) comparing the prevalence of each medical condition in skin cancer cases to controls (Lanoy et al, 2010). We focused on associations that met statistical significance after Benjamini and Hochberg correction to account for multiple comparisons (P-value <0.05, after correction based on 6 skin cancers subtypes × 12 autoimmune conditions=72 tests) (Keselman et al, 2002), but we also present uncorrected 95%CIs for ORs that indicate associations of borderline significance (uncorrected P-value <0.05).
Results
Characteristics of 44 613 skin cancer cases and 178 452 controls (corresponding to 134 779 unique control individuals) are shown in Table 1. Among 1540 appendageal carcinoma cases, the most frequent histological subtypes were sebaceous carcinoma (N=610), skin appendage carcinoma (N=316), and sweat gland adenocarcinoma (N=144). Of the 2652 cutaneous NHLs, 1854 were T-cell NHLs (of which 945 were mycosis fungoides/Sezary syndrome (MF/SS)) and 798 were B-cell NHLs. Among 1324 sarcomas, the most frequent histological subtypes were malignant fibrous histiocytoma (N=682), dermatofibrosarcoma (N=235), haemangiosarcoma (N=173), and leiomyosarcoma (N=121).
As shown in Table 2, an increased risk of Merkel cell carcinoma was observed in persons with rheumatoid arthritis (OR 1.39). Psoriasis was associated with an increased risk of cutaneous NHL (OR 3.20), caused by associations specifically with MF/SS (OR 5.81, 95% CI 4.43–7.63) and other cutaneous T-cell NHLs (OR 2.90, 95% CI 2.07–4.06), whereas cutaneous B-cell NHL risk was not elevated (OR 1.04, 95% CI 0.57–1.89). Ulcerative colitis was associated with risk of KS (OR 2.76), and an increased risk of sarcoma was found with Graves disease (OR 2.62). Among sarcomas, when we considered only malignant fibrous histiocytoma, the association with Graves disease remained significant (OR 3.24, 95% CI 1.33–7.89). Finally, melanoma risk was decreased in individuals with giant cell arteritis (OR 0.70). Table 2 also shows several additional associations of borderline significance.
Discussion
We evaluated the risk of non-keratinocytic skin cancers in patients with autoimmune conditions in a case–control study among elderly US adults. Some associations that met our criterion for significance are likely to be explained by chronic inflammatory involvement of the skin or immune modulating therapies given for autoimmune conditions. The strong association that we observed between psoriasis and T-cell NHL (particularly MF/SS) is a biologically plausible manifestation of chronic inflammation (Ekstrom Smedby et al, 2008; Anderson et al, 2009). An alternative explanation could be misdiagnosis, in that cutaneous lymphoma can initially present as a chronic plaque-like lesion that might be mistaken for psoriasis (Ekstrom Smedby et al, 2008). In contrast, psoriasis was neither associated with cutaneous B-cell NHL nor, in a prior study (Anderson et al, 2009), with non-cutaneous T-cell NHL.
Our finding of elevated KS risk associated with ulcerative colitis is supported by several case reports in such patients receiving immunosuppressive drugs (Svrcek et al, 2009). The association of sarcoma with Graves disease mentioned above may relate to immunosuppressive therapies (Simon et al, 2009), as may that of rheumatoid arthritis with Merkel cell carcinoma, which is increased in HIV-infected people and transplant recipients (Lanoy et al, 2010) and may be caused by a recently discovered polyomavirus. Finally, we observed an unexpected significant deficit of melanoma among people with giant cell arteritis. A Danish study found no association between autoimmune diseases and melanoma incidence (Kaae et al, 2007), although others have reported an increased melanoma risk with pernicious anaemia (Brinton et al, 1989) and psoriasis (Stern, 2001).
The strength of our study is its large size, allowing us to evaluate associations between uncommon autoimmune conditions and skin cancers. Nonetheless, limitations of our study include that it was restricted to elderly adults, that basal and squamous cell skin cancers were not covered, and that we could not ascertain the presence of medical conditions below 65 years of age; we also had no data on immunosuppressive treatments.
Several associations identified between autoimmune conditions and skin cancer risk suggest that such conditions affecting the skin, or treated with immunosuppression promote the development of skin cancer; their further investigation will require additional large studies.
Change history
29 March 2012
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, Berndt SI, Ricker W, Parsons R, Engels EA (2009) Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125: 398–405
Brinton LA, Gridley G, Hrubec Z, Hoover R, Fraumeni Jr JF (1989) Cancer risk following pernicious anaemia. Br J Cancer 59: 810–813
Ekstrom Smedby K, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjose S, Chiu BC, Dal Maso L, Cocco P, Maynadie M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111: 4029–4038
Gruber SB, Armstrong BK (2006) Cutaneous, ocular melanoma. In Cancer Epidemiology, Prevention, Schottenfeld D, Fraumeni JF Jr E (eds) 3rd edn, pp 1196–1229. Oxford University Press: New York
Kaae J, Wohlfahrt J, Boyd HA, Wulf HC, Biggar RJ, Melbye M (2007) The impact of autoimmune diseases on the incidence and prognosis of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 16: 1840–1844
Keselman HJ, Cribbie R, Holland B (2002) Controlling the rate of Type I error over a large set of statistical tests. Br J Math Stat Psychol 55: 27–39
Lanoy E, Costagliola D, Engels EA (2010) Skin cancers associated with HIV infection and solid organ transplant among elderly adults. Int J Cancer 126: 1724–1731
Simon Z, Ress Z, Toldi J, Trauninger A, Miltenyi Z, Illes A (2009) Rare association of Hodgkin lymphoma, Graves’ disease and myasthenia gravis complicated by post-radiation neurofibrosarcoma: coincidence or genetic susceptibility? Int J Hematol 89: 523–528
Stern RS (2001) The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 44: 755–761
Svrcek M, Tiret E, Bennis M, Guyot P, Flejou JF (2009) KSHV/HHV8-associated intestinal Kaposi's sarcoma in patient with ulcerative colitis receiving immunosuppressive drugs: report of a case. Dis Colon Rectum 52: 154–158
Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40: IV–18
Acknowledgements
This study was funded by the Intramural Research Program of the National Cancer Institute. The study used the linked SEER-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. We acknowledge the efforts of the Applied Research Program, National Cancer Institute; the Office of Research, Development and Information, Centers for Medicare and Medicaid Services; Information Management Services, Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program cancer registries in the creation of the SEER-Medicare database. We thank Winnie Ricker and Ruth Parsons, Information Management Services, Rockville, MD for constructing the analysis data set.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Lanoy, E., Engels, E. Skin cancers associated with autoimmune conditions among elderly adults. Br J Cancer 103, 112–114 (2010). https://doi.org/10.1038/sj.bjc.6605733
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6605733
Keywords
This article is cited by
-
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma
Genome Medicine (2020)
-
Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma
American Journal of Clinical Dermatology (2019)
-
Comorbidities in polymyalgia rheumatica: a systematic review
Arthritis Research & Therapy (2018)
-
History of chronic inflammatory disorders increases the risk of Merkel cell carcinoma, but does not correlate with Merkel cell polyomavirus infection
British Journal of Cancer (2017)
-
Endometriosis and the risk of skin cancer: a prospective cohort study
Cancer Causes & Control (2017)